Tokyo, Jan 27, 2006 (JCN) - Astellas Pharma announced on January 27 that the company has established Astellas Venture Management LLC (AVM) in California. Capitalized at $67.5 million, AVM manages all venture investment business of former Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical as well as newly established limited partnership Astellas Venture Fund I L.P.
